ArticleBMC cancer2024

Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.

Jing You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.